A veteran newspaper reporter once said that if you wrote a story six months ago, it was fine to follow up again, because nobody would remember you wrote that other piece. Now that news moves at electron speed on the Web, we figure people can barely remember what we wrote just a couple weeks ago.
So, as another quarter has been put on the books, it’s worth taking another look at some of the most memorable stories we’ve done in the past three months. Maybe you missed them the first time around, or maybe we can gain some additional perspective on them with the benefit of hindsight.
Regardless, here’s a sampling of 20 of our Editor’s Picks from the past three months. The selections represent most everything we cover: the people and companies of the Northwest technology and life sciences communities. Some of these stories were quirky one-off features, and others represent a long-running narrative that will keep us interested for years to come. So enjoy the stories, enjoy the long holiday weekend, and we’ll be back on the beat on Tuesday.
Greg’s (and Thea’s) Top 10 technology stories of the second quarter:
“Toward a New Land Speed Record: A Day in the Life of the North American Eagle Turbojet Car“
“Beaming Power to UAVs, Space Elevators, and Someday Earth: The Lasermotive Story“
“Twitter Buys Seattle’s Cloudhopper to Expand SMS Service Globally: The Story Behind the Deal“
“How to Predict Whether a Startup Will Succeed or Fail: Testing the Disruptive Innovation Model“
“Bobber Interactive Looks to Make Financial Services More Social and “Gamified” For Teens“
“Novel, Backed by Vancouver VCs, Uses Gaming Tech to Make Business Simulations for Companies“
“How Seattle Startups Could Lead the World: Five Technology Themes to Watch“
Luke’s Top 10 life sciences stories of the second quarter:
“Dendreon Makes History: FDA Approves First Active Immune-Booster to Fight Cancer“
“Alder Seeks to Treat Cancer in a Radical Way, Fighting Inflammation, Not Tumors“
“Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug“
“Leroy Hood’s Personalized Medicine Vision Enters Proving Ground at Ohio State“
“How Emerald BioStructures Escaped deCode’s Bankruptcy With Help From Boston VCs“
“ZymoGenetics Melanoma Drug Passes Small Study, Gets Overshadowed by Bristol-Myers“
“Theraclone Sciences CEO David Fanning Dies Suddenly“
“Qliance Nails $6M from Bezos, Dell, Drew Carey For Primary Care That Avoids Insurance“
“Presage Biosciences, a Spinoff from the Fred Hutch, Adds CEO, Angel Bucks, Big Pharma Customers“